We conducted an association study between genetic variants of C-type natriuretic peptide gene (CNP ) and hypertension in a Japanese population. We found four genetic variants, two in the promoter region, one missense mutation, and one in the 3 -untranslated region (3 -UTR), and genotyped all four variants in 2,006 subjects recruited from the Suita study. One of the variants, G2628A in 3 -UTR, was found to be associated with blood pressure. Multiple logistic analyses indicated that the genotype of the G2628A polymorphism tissues and directly influence blood pressure and body fluid homeostasis (4). Although CNP is produced in endothelial cells, its level in the peripheral circulation is very low and does not appear to be associated with blood pressure status (5). On the other hand, the expression level of CNP in the central nervous system has been reported to be high (6), and intracerebroventricular CNP has been reported to lower blood pressure (7). These observations strongly suggest that CNP functions as a neuropeptide in regulating blood pressure and body fluid homeostasis. Thus, CNP is a candidate gene for human essential hypertension.
Introduction
Interactions between genetic and environmental factors are thought to play important roles in the pathogenesis of hypertension. The use of association studies in large epidemiological cohorts with a large number of single-nucleotide polymorphisms throughout a single gene or throughout the entire genome is a new strategy for identifying genes that contribute to high blood pressure (1) (2) (3) . In the present study, we applied this strategy to the C-type natriuretic peptide (CNP) gene (CNP) to examine whether its genetic variants influence blood pressure.
The natriuretic peptides play important roles in cardiovascular homeostasis. A-type and B-type natriuretic peptides (ANP and BNP) are mainly produced in cardiac
Methods

Subjects
The selection criteria and design of the Suita study have been described previously (2) . In the present study, subject information was made anonymous. The present study was approved by the Ethics Committee of the National Cardiovascular Center and by the Committee on Genetic Analysis and Genetic Therapy of the National Cardiovascular Center. Informed consent on genetic analysis was obtained from about 3,700 subjects, and the genotype of CNP was determined in 2,006 consecutive subjects. Subjects were categorized as hypertensives when they had a systolic blood pressure of 140 mmHg or a diastolic blood pressure of 90 mmHg. Subjects who were taking hypertensive medication were also categorized as hypertensives.
DNA Studies
Genomic DNA from 24 subjects was used as a template for sequence analyses. The promoter (up to 1 kb) and coding regions (exons 1 and 2) were sequenced. The region of the promoter and exon 1 was amplified by the following primers: 5 -ggaagttgaccacctgtcacggct-3 (570-594 according to GenBank accession No. E03598) and 5 -cttccctctctc ctgggtcctgc- 3 (1904-1882) . The region of exon 1, intron 1, and exon 2 was amplified by the following primers: 5 -ctgcaaatggagttcccctgtg-3 (1339-1360) and 5 -gaagccaggtgg gttcaaccag-3 (2792-2770). Polymorphisms were determined by the TaqMan system. The primers and probes are summarized in Table 1 .
Statistical Analyses
Values are expressed as the means SEM. All statistical analyses were performed with the JMP statistical package (SAS Institute Inc., Cary, USA). Multiple regression and multiple logistic analyses were performed with other covariates. Residuals of blood pressure values were calculated by adjusting for sex, age, and body mass index (BMI). Differences in numerical data among the groups were calculated by one-way analysis of variance (ANOVA) and the unpaired t-test. Differences in frequencies and the degree of linkage disequilibrium were tested by contingency table analysis. The nucleotide numbers of polymorphisms are given according to the sequence in the GenBank database (accession No. E03598). G733A and G1612C are in the promoter region, G2347T is in exon 2 and shows an amino-acid change of Gly61Val, and G2628A is in the 3 -untranslated region of CNP mRNA. 
Results
CNP Polymorphisms
We found 4 polymorphisms in CNP, which are summarized in Table 1 . We found two polymorphisms in the promoter region, one polymorphism in the coding region (exon 2) that accompanied an amino acid change from Gly to Val at amino acid position 61, and one polymorphism in the 3 -non coding region. The pairwise linkage disequilibriums are summarized in Table 2 . The genotype frequencies are given in Table 3 . Table 3 shows characteristics of the study population. The GT genotype of the G2347T polymorphism is more frequent in hypertensives. The frequencies of the AG and AA genotypes in G2628A polymorphism are higher among hypertensives. Multiple logistic analyses which included sex, age, BMI, alcohol consumption, and genotype of CNP indicated that sex ( p 0.0288), age ( p 0.0001), BMI ( p 0.0001), alcohol consumption ( p 0.0002), and A2628G genotype (GG 1, GA AA 2) ( p 0.0034) were predictors of hypertensive status. The odds ratio of the GA AA genotype of the G2628A polymorphism for hypertension was 1.40 (95% confidence interval (CI) 1.12-1.75) over the GG genotype. It is generally accepted that genetic effects are more evident among younger subjects, whereas the phenotypes of older subjects are more strongly influenced by environmental factors. Therefore, we analyzed the effects of genotypes on blood pressure among younger subjects. Table 4 shows characteristics of the study population aged below 65 years according to the G2628A polymorphism. Multiple logistic analysis in this younger subpopulation indicated that age ( p 0.0001), BMI ( p 0.0001), alcohol consumption ( p 0.0029), and A2628G genotype (GG 1, GA AA 2) ( p 0.0024) were predictors of hypertensive status. The odds ratio of the GA AA genotype of the G2628A polymorphism for hypertension was 1.58 (95% CI 1.18-2.12) over the GG genotype. Thus, the CNP G2628A polymorphism made an even greater contribution to hypertension in the younger subpopulation.
Association Study
Discussion
CNP is abundantly expressed throughout the brain, with particularly high concentrations found in the anterior pituitary (6) . Since the receptor for CNP with guanylyl cyclase activity (natriuretic peptide receptor B; NPRB) is abundant in tissues of neural origin and is scarce in peripheral vasculature, CNP has less of a direct peripheral depressor effect than ANP and BNP (8, 9) . However, intracerebroventricular infusion of CNP has been reported to lower blood pressure and aldosterone secretion (7). Therefore, it is possible that genetic variations of CNP may influence blood pressure through their effects on the central nervous system.
In terms of salt sensitivity, we have studied the influence of genetic variants of SCNN1A, SCNN1G and CYP11B2 on blood pressure in the same study population (10) (11) (12) . Our results showed that a genetic variant of SCNN1A had a significant influence on blood pressure. In future studies, it would thus be intriguing to study the relationship between the effectiveness of diuretic therapy and genetic variants of SCNN1A and CNP.
In the present work, we studied 4 polymorphisms of CNP, two in the promoter region, one in the coding region that is accompanied by an amino-acid change, and one in the 3 -untranslated region (3 -UTR). The missense mutation is outside the loop structure that is very important for biological activity (4), and may not have biological significance. Only the G2628A genotype in 3 -UTR was associated with blood pressure. We speculated that this 3 -UTR polymorphism may influence the stability of CNP mRNA (13) . We constructed artificial luciferase genes which had CNP 3 -UTRs. Transient expression analyses indicated that this 3 -UTR poly- CNP has been reported to be located at chromosome 2q24-qter. Four other genes with unknown functions are reported to exist within 50 kb of CNP (contig NT_022157.7). The distance for tight linkage disequilibrium may vary according to the chromosomal region and race, and may be beyond 50 kb (14) . In this sense, it may be necessary to sequence and genotype a wider range of this chromosomal region to identify the genetic variations that truly influence blood pressure.
